Form 4 for SXTP 60 DEGREES PHARMACEUTICALS, INC.
Accepted 2025-08-14 00:00:00 ET · period of report 2025-01-17 · accession 0001213900-25-076983 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-14 | 2025-01-17 | SXTP | Landon Kristen | COO | A - Grant | $0.00 | +4,540 | 4,540 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-17 | A | A | 4,540 | $0.00 | 4,540 | D | — | — | (F1) This Form 4 is being filed late due to an inadvertent administrative error. (F2) The number of shares has been adjusted to reflect the 1-for-5 reverse stock split effected by the Issuer on February 24, 2025. |